{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:50:35Z","timestamp":1792608635473,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jiac.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T03:06:12Z","timestamp":1598583972000},"page":"45-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan"],"prefix":"10.1016","volume":"27","author":[{"given":"Naoki","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitake","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.rmed.2008.06.022","article-title":"Epidemiology and clinical features of Mycoplasma pneumoniae infection in children","volume":"102","author":"Defilippi","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41598-018-19734-y","article-title":"Clinical evaluation of the immunochromatographic system using silver amplification for the rapid detection of Mycoplasma pneumoniae","volume":"8","author":"Namkoong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2020.08.006_bib4","first-page":"974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment","volume":"7","author":"Pereyre","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ccm.2016.11.011","article-title":"Atypical pneumonia: updates on Legionella, Chlamydophila, and Mycoplasma pneumonia","volume":"38","author":"Sharma","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jiac.2020.08.006_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3201\/eid2310.170106","article-title":"Macrolide-resistant Mycoplasma pneumoniae infection, Japan","volume":"23","author":"Tanaka","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1440-1843.2011.02102.x","article-title":"Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasama pneumoniae pneumonia in paediatric patients","volume":"17","author":"Kawai","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.jiac.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-12-126","article-title":"Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia","volume":"12","author":"Miyashita","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fmicb.2016.00513","article-title":"A\u00a0compendium for Mycoplasma pneumoniae","volume":"7","author":"Parrott","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1183\/09031936.00172510","article-title":"Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia","volume":"37","author":"Cardinale","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"ofv106","DOI":"10.1093\/ofid\/ofv106","article-title":"Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States","volume":"2","author":"Diaz","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10156-009-0715-7","article-title":"A\u00a0comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients","volume":"15","author":"Matsubara","year":"2009","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/AAC.00737-13","article-title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy","volume":"57","author":"Miyashita","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ppul.22706","article-title":"Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan","volume":"48","author":"Wu","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jiac.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/AAC.39.12.2770","article-title":"Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae","volume":"39","author":"Lucier","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.45.1.1-12.2001","article-title":"Macrolide resistance conferred by base substitutions in 23S rRNA","volume":"45","author":"Vester","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib17","article-title":"A\u00a0fulminant cases of acute respiratory distress syndrome associated with Mycoplasma pneumonia treated with nasal high-flow oxygen therapy","volume":"2018","author":"Kawakami","year":"2018","journal-title":"Case Rep Crit Care"},{"key":"10.1016\/j.jiac.2020.08.006_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/mdr.2018.0295","article-title":"Prevalence and clinical features of community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae isolated from adults in Jeju Island","volume":"25","author":"Choi","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jiac.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.00048-13","article-title":"Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients","volume":"57","author":"Kawai","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib20","first-page":"801","article-title":"American academy of pediatrics","volume":"vol. 520","author":"Pickering","year":"2012"},{"key":"10.1016\/j.jiac.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/JCM.02840-12","article-title":"Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children","volume":"51","author":"Cardinale","year":"2013","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20302865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20302865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:20Z","timestamp":1761159680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20302865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1341321X20302865"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.08.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of macrolide-resistant Mycoplasma pneumoniae by age distribution in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}